The role of cell signalling in the crosstalk between autophagy and apoptosis

被引:334
作者
Booth, Laurence A. [1 ]
Tavallai, Seyedmehrad [1 ]
Hamed, Hossein A. [1 ]
Cruickshanks, Nichola [1 ]
Dent, Paul [1 ,2 ]
机构
[1] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA
[2] Virginia Commonwealth Univ, Virginia Inst Mol Med, Richmond, VA 23298 USA
关键词
Apoptosis; Autophagy; Sorafenib; Caspase; Autophagosome; SORAFENIB INDUCES APOPTOSIS; BCL-2; FAMILY-MEMBERS; BECLIN; DEATH; INHIBITION; P53; PHOSPHORYLATION; ACTIVATION; CASPASE-8; PROTEINS;
D O I
10.1016/j.cellsig.2013.11.028
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Not surprisingly, the death of a cell is a complex and well controlled process. For several decades, apoptosis, the first genetically programmed death process to be identified has taken centre stage as the principal mechanism of programmed cell death (type I cell death) in mammalian tissues. Apoptosis has been extensively studied and its contribution to the pathogenesis of disease well documented. However, apoptosis does not function alone in determining the fate of a cell. More recently, autophagy, a process in which de novo formed membrane enclosed vesicles engulf and consume cellular components, has been shown to engage in complex interplay with apoptosis. As a result, cell death has been subdivided into the categories apoptosis (Type I), autophagic cell death (Type II), and necrosis (Type III). The boundary between Type I and II cell death is not completely clear and as we will discuss in this review and perhaps a discrete difference does not exist, due to intrinsic factors among different cell types and crosstalk among organelles within each cell type. Apoptosis may begin with autophagy and autophagy can often end with apoptosis, inhibition or a blockade of caspase activity may lead a cell to default into Type II cell death from Type I. Published by Elsevier Inc.
引用
收藏
页码:549 / 555
页数:7
相关论文
共 74 条
[1]   Bcl-2-regulated apoptosis: mechanism and therapeutic potential [J].
Adams, Jerry M. ;
Cory, Suzanne .
CURRENT OPINION IN IMMUNOLOGY, 2007, 19 (05) :488-496
[2]  
Bareford M.D., 2012, J BIOL CHEM, V287, P32113
[3]   Atg4D at the interface between autophagy and apoptosis [J].
Betin, Virginie M. S. ;
Lane, Jon D. .
AUTOPHAGY, 2009, 5 (07) :1057-1059
[4]  
Cárdenas-Aguayo MD, 2003, J HEMATOTH STEM CELL, V12, P735
[5]   Antagonism of Beclin 1-dependent autophagy by BCL-2 at the endoplasmic reticulum requires NAF-1 [J].
Chang, Natasha C. ;
Nguyen, Mai ;
Germain, Marc ;
Shore, Gordon C. .
EMBO JOURNAL, 2010, 29 (03) :606-618
[6]   Caspase-mediated cleavage of ATG6/Beclin-1 links apoptosis to autophagy in HeLa cells [J].
Cho, Dong-Hyung ;
Jo, Yoon Kyung ;
Hwang, Jung Jin ;
Lee, Yoo Mee ;
Roh, Seon Ae ;
Kim, Jin Cheon .
CANCER LETTERS, 2009, 274 (01) :95-100
[7]   Bcl-2 complexed with Beclin-1 maintains full anti-apoptotic function [J].
Ciechomska, I. A. ;
Goemans, G. C. ;
Skepper, J. N. ;
Tolkovsky, A. M. .
ONCOGENE, 2009, 28 (21) :2128-2141
[8]   DRAM, a p53-induced modulator of autophagy, is critical for apoptosis [J].
Crighton, Diane ;
Wilkinson, Simon ;
O'Prey, Jim ;
Syed, Nelofer ;
Smith, Paul ;
Harrison, Paul R. ;
Gasco, Milena ;
Garrone, Ornella ;
Crook, Tim ;
Ryan, Kevin M. .
CELL, 2006, 126 (01) :121-134
[9]   Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells [J].
Daido, S ;
Kanzawa, T ;
Yamamoto, A ;
Takeuchi, H ;
Kondo, Y ;
Kondo, S .
CANCER RESEARCH, 2004, 64 (12) :4286-4293
[10]   Inhibiting oncogenic signaling by sorafenib activates PUMA via GSK3β and NF-κB to suppress tumor cell growth [J].
Dudgeon, C. ;
Peng, R. ;
Wang, P. ;
Sebastiani, A. ;
Yu, J. ;
Zhang, L. .
ONCOGENE, 2012, 31 (46) :4848-4858